Figure 2 : Pathology and IHC of Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) , (A)H&E , (B)LCA+,
(C) CD3+,(D)CD7+,(E)CD5- , (F) CD20-, (G)CD30-,(H)Ki67 :70-80%